All three major US stock indexes were up in late-morning trading Tuesday, as oil prices pulled back after soaring due to the war in Iran.
In company news, Amazon.com (AMZN) has commenced a US investment-grade debt sale in as many as 11 parts, ranging from two to 50 years and is planning to sell euro bonds in eight parts, with maturities ranging from two to 38 years, Bloomberg reported Tuesday, citing a person familiar with the matter. The tech giant is targeting $25 billion to $30 billion from the US sale and 10 billion euros in the overseas offering, Bloomberg reported. Amazon shares were up 0.6% around midday.
BioNTech (BNTX) said Tuesday its co-founders, Ugur Sahin and Ozlem Tureci, plan to establish a new independent company focused on next-generation mRNA technologies. In addition, the company reported a Q4 adjusted loss Tuesday of 0.33 euro ($0.38) per diluted share, swinging from earnings of 1.79 euros a year earlier and compared to the FactSet consensus analyst estimate of a loss of 0.16 euro. Fourth-quarter revenue was 907.4 million euros, down from 1.19 billion euros a year ago but above the FactSet consensus of 768.3 million euros. For 2026, the company said it expects revenue of 2 billion euros to 2.30 billion euros, below the FactSet consensus of 2.75 billion euros. BioNTech shares were down 21.7%.
Nvidia (NVDA) and Thinking Machines Lab said Tuesday they have formed a multi-year partnership to deploy at least one gigawatt of Nvidia Vera Rubin hardware. The deployment, expected to be complete by early 2027, will support frontier model training and platforms for customizable AI, the companies said. Nvidia shares were up 1.9%.
AT&T (T) said Tuesday it plans to invest over $250 billion in US telecommunications infrastructure through 2030. The investment will expand fiber and wireless services, upgrade critical infrastructure and bolster network resilience and security, the company said. AT&T shares were up 0.5%.
Meta Platforms (META) has acquired Moltbook, a social media network created for AI programs, Axios reported Tuesday, citing a company spokesperson. Financial terms of the deal were not shared, but the agreement is expected to be finalized in the middle of March, the report said. Meta shares were up 1.5%.
Novo Nordisk (NVO) said Tuesday it received a warning letter from the US Food and Drug Administration on March 5 related to a Post-marketing Adverse Drug Experience inspection conducted in early 2025 at its Plainsboro, New Jersey site. The FDA said in the letter that the company failed "to develop written procedures for the surveillance, receipt, evaluation, and reporting" of post-marketing adverse drug experiences to the agency as required under the Code of Federal Regulations. Novo shares were down 3.4%.
Price: 215.01, Change: +1.52, Percent Change: +0.71
Comments